Sequences encoding human neoplastic marker
OwnerD. James Morre, Dorothy M. Morre +1inventors
InventorsD. James Morre, Dorothy M. Morre, Pin-ju Chueh
Life of this patent
Estimating the term…
Loading patent…
OwnerD. James Morre, Dorothy M. Morre +1inventors
InventorsD. James Morre, Dorothy M. Morre, Pin-ju Chueh
Estimating the term…
The present disclosure provides the nucleotide sequence encoding a cell surface NADH oxidase/protein disulfide-thiol interchange protein (tNOX) characteristic of neoplastic and virus-infected cells. Also provided are recombinant DNA molecules comprising a sequence portion encoding full length or truncated tNOX, recombinant host cell which express full length or truncated tNOX, methods for recombinant production of tNOX or truncated tNOX, and diagnostic methods which employ either nucleotide sequences of the neoplastic cell-specific tNOX or antibodies specific for the rNOX protein.
A non-naturally occurring recombinant DNA molecule comprising a portion encoding an NADH oxidase/protein disulfide-thiol interchange polypeptide, said portion consisting essentially of a nucleotide sequence selected from the group consisting of SEQ ID NO:
A method for recombinantly producing a NADH oxidase/protein disulfide-thiol interchange active polypeptide in a host cell, said method comprising the steps of:
A method for determining neoplasia in a mammal, said method comprising the steps of:
An antibody preparation which specifically binds to an antibody selected from the group consisting of a protein characterized by an amino acid sequence as given in SEQ ID NO:
A method for determining neoplasia in a mammal, said method comprising the steps of:
Dependencies are inferred from the claim text.